Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

H. Lee Moffitt Cancer Center and Research Institute

Status: Active, not recruiting

Conditions: High Grade Cervical Dysplasia; Cervical Cancer; Smoking Cessation

Treatments: Drug: Nicotine patch; Behavioral: Motivation and Problem Solving (MAPS) intervention; Drug: Nicotine Lozenge; Behavioral: Smoking Cessation treatment delivered by Tobacco Free Florida Quitline

Study type: Interventional

Funder types: Other

Identifiers

NCT05645146

MCC-21885

Details and patient eligibility

About

The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.

Enrollment: 360 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least 100 cigarettes or more smoked in participants lifetime
• Speaks English
• Currently smoke 1 cigarette or more in the past 30 days
• History of cervical cancer or high grade cervical dysplasia
• Has a working smartphone
• Has a valid home address
• Reside in Florida at the time of study enrollment

Exclusion criteria

• Receiving behavioral or pharmacological tobacco treatment
• Household member enrolled in this study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

360 participants in 2 patient groups

Group 1: Standard Treatment

Active Comparator group

Description:

Participants will receive a connection to the Tobacco Free Florida Quitline and a 12 week supply of nicotine replacement therapy (the patch and lozenges)

Treatment:

Behavioral: Smoking Cessation treatment delivered by Tobacco Free Florida Quitline

Drug: Nicotine Lozenge

Drug: Nicotine patch

Group 2: Motivation and Problem Solving (MAPS) counseling

Experimental group

Description:

Participants will receive a 12 week supply of nicotine replacement therapy (the patch and lozenges) along with the MAPS intervention, which consists of 6 MAPS counseling calls over 12 months, and individually tailored SMS text content driven by monthly smartphone delivered check-ins for 24 months

Treatment:

Drug: Nicotine Lozenge

Behavioral: Motivation and Problem Solving (MAPS) intervention

Drug: Nicotine patch